Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Tryn Stimart

The proxy statement of AbCellera Biologics Inc. reports total compensation of $2,343,388 for Tryn Stimart in fiscal 2025, including a base salary of $470,000. Disclosed compensation is on record for 7 fiscal years. Tryn Stimart has spoken on 1 earnings call across 1 company, most recently for AbCellera Biologics Inc. on February 24, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at AbCellera Biologics Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 AbCellera Biologics Inc. (ABCL) $470,000 $2,343,388
2024 AbCellera Biologics Inc. (ABCL) $460,000 $2,890,567
2023 AbCellera Biologics Inc. (ABCL) $460,000 $667,690
2022 AbCellera Biologics Inc. (ABCL) $450,000 $3,676,733
2021 AbCellera Biologics Inc. (ABCL) $400,000 $3,063,678
2020 AbCellera Biologics Inc. (ABCL) $337,235 $4,434,343
2019 AbCellera Biologics Inc. (ABCL) $115,152 $651,870

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.